PSCA Antikörper (C-Term)
Kurzübersicht für PSCA Antikörper (C-Term) (ABIN927989)
Target
Alle PSCA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- PSCA antibody was raised in rabbit using the C terminal of PSCA as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PSCA Blocking Peptide, (ABIN5615607), is also available for use as a blocking control in assays to test for specificity of this PSCA antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PSCA (Prostate Stem Cell Antigen (PSCA))
-
Andere Bezeichnung
- PSCA
-
Hintergrund
- This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. Synonyms: Polyclonal PSCA antibody, Anti-PSCA antibody, prostate stem cell antigen antibody, PRO232 antibody.
Target
-